Blog
RSS FeedPosted by Michael Wonder on 21 May 2019
Novartis CEO: gene therapy offers hope of cures in one treatment, but US needs new pricing and payment model
17 May 2019 - We live in an incredible era of progress in human health. Advances in cell and gene ...
Posted by Michael Wonder on 21 May 2019
Extremely high drug prices should be reviewed for appropriateness
21 May 2019 - As medicine advances, a succession of highly efficacious but extremely costly therapeutic drugs have arrived on ...
Posted by Michael Wonder on 21 May 2019
Could drug price transparency raise prices? These lobbyists and lawmakers think so.
21 May 2019 - Objections made on disclosing rebates and revealing data about free samples. ...
Posted by Michael Wonder on 21 May 2019
The global battle over high drug prices
21 May 2019 - Western countries, as well as poor ones, are demanding transparency in the cost of drugs. ...
Posted by Michael Wonder on 20 May 2019
A leading HIV drug is way overpriced in the US
17 May 2019 - A House hearing over the price of Truvada shows a particularly glaring example of a rampant industry ...
Posted by Michael Wonder on 20 May 2019
Trump administration postpones some Medicare drug cost proposals
17 May 2019 - The administration says it will not give health plans the authority to negotiate pricing for certain drugs ...
Posted by Michael Wonder on 19 May 2019
Trump Administration caves to pharma on Medicare Part D 'protected classes' reform
17 May 2019 - The Trump administration has shelved a proposal that would have stymied egregious price hikes in the ...
Posted by Michael Wonder on 19 May 2019
Gilead’s $21,000 drug is being blamed for a plateau in HIV prevention
17 May 2019 - AIDS activists, CEO O’Day square off at congressional hearing. ...
Posted by Michael Wonder on 19 May 2019
San Francisco, Santa Clara, Alameda counties join Governor Newsom to lower drug prices
16 May 2019 - San Francisco, Santa Clara and Alameda counties joined on Thursday Governor Gavin Newsom’s ambitious plan to ...
Posted by Michael Wonder on 19 May 2019
Trump administration backs off Medicare drug pricing rule
16 May 2019 - The Trump administration on Thursday backed off a controversial Medicare drug pricing proposal that would have ...
Posted by Michael Wonder on 19 May 2019
House passes legislation aiming to shore up health law and lower drug costs
16 May 2019 - The House on Thursday passed a suite of health care bills that tied shoring up the ...
Posted by Michael Wonder on 19 May 2019
Push for drug pricing transparency strikes a nerve with industry
19 May 2019 - Ahead of the World Health Assembly in Geneva, an Italian draft resolution to end secrecy around ...
Posted by Michael Wonder on 18 May 2019
Trump just pulled his punch on drug prices
18 May 2019 - Actually cutting health care costs will require overcoming opposition instead of ducking it, as his administration did ...
Posted by Michael Wonder on 16 May 2019
Instalment payments could be used across gene therapy space, Spark CEO says
16 May 2019 - In a fireside chat at the recently concluded Veeva Summit in Philadelphia, Jeff Marrazzo said payment over ...
Posted by Michael Wonder on 16 May 2019
CMS takes action to lower prescription drug prices and increase transparency
16 May 2019 - Final rule modernises the Medicare Advantage & Medicare Part D programs. ...